Main Menu


Publications Highlights View all by category

Types of Publications

Journal Articles

Campbell, J., Ryan, C.J., Brough, R., Bajrami, I., Pemberton, H.N., Chong, I.Y., Costa-Cabral, S., Frankum, J., Gulati, A., Holme, H., et al. (2016). Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines. Cell rep, Vol.14 (10), pp. 2490-2501.  show abstract

Workman, P., Clarke, P.A. & Al-Lazikani, B. (2016). Blocking the survival of the nastiest by HSP90 inhibition. Oncotarget, Vol.7 (4), pp. 3658-3661.  show abstract

Patel, M.N., Halling-Brown, M.D., Tym, J.E., Workman, P. & Al-Lazikani, B. (2013). Objective assessment of cancer genes for drug discovery. Nat rev drug discov, Vol.12 (1), pp. 35-50.  show abstract

Halling-Brown, M.D., Bulusu, K.C., Patel, M., Tym, J.E. & Al-Lazikani, B. (2012). canSAR: an integrated cancer public translational research and drug discovery resource. Nucleic acids res, Vol.40 (Database issue), pp. D947-D956.  show abstract

Gaulton, A., Bellis, L.J., Bento, A.P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012). ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic acids res, Vol.40 (Database issue), pp. D1100-D1107.  show abstract

Al-Lazikani, B., Banerji, U. & Workman, P. (2012). Combinatorial drug therapy for cancer in the post-genomic era. Nat biotechnol, Vol.30 (7), pp. 679-692.  show abstract

Berriman, M., Haas, B.J., LoVerde, P.T., Wilson, R.A., Dillon, G.P., Cerqueira, G.C., Mashiyama, S.T., Al-Lazikani, B., Andrade, L.F., Ashton, P.D., et al. (2009). The genome of the blood fluke Schistosoma mansoni. Nature, Vol.460 (7253), pp. 352-358.  show abstract

Ag├╝ero, F., Al-Lazikani, B., Aslett, M., Berriman, M., Buckner, F.S., Campbell, R.K., Carmona, S., Carruthers, I.M., Chan, A.W., Chen, F., et al. (2008). Genomic-scale prioritization of drug targets: the TDR Targets database. Nat rev drug discov, Vol.7 (11), pp. 900-907.  show abstract

Overington, J.P., Al-Lazikani, B. & Hopkins, A.L. (2006). How many drug targets are there?. Nat rev drug discov, Vol.5 (12), pp. 993-996.  show abstract

Santos, R., Ursu, O., Gaulton, A., Bento, A.P., Donadi, R.S., Bologa, C.G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T.I., et al. A comprehensive map of molecular drug targets. Nat rev drug discov, Vol.16 (1), pp. 19-34.  show abstract

In this section

Professional activities Publications Resources

Division of Cancer Therapeutics

The Division of Cancer Therapeutics has an unrivalled track record at discovering novel cancer treatments and biomarkers.